New guidelines prevent costly adverse drug reactions.
New guidelines on disease management of drug hypersensitivity have been released by the American College of Allergy, Asthma, & Immunology. The guidelines deal extensively with preventing adverse drug reactions, which represent a major source of unnecessary expense for hospitals and health plans.
D000465:Algorithms; D019091:Critical Pathways; D004342:Drug Hypersensitivity / Q000191:economics / Q000517:prevention & control*; D064420:Drug-Related Side Effects and Adverse Reactions; D017048:Health Care Costs; D006801:Humans; D008509:Medication Systems / Q000592:standards*; D010593:Pharmaceutical Services / Q000592:standards*; D012308:Risk Management; D014481:United States